EAM
ONCE

EverPoint Asset Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

EverPoint Asset Management’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-60,000
Closed -$4.65M – 643
2015
Q1 		$4.65M Buy
+60,000
New +$3.46M 0.09% 299

Other funds holding ONCE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

EverPoint Asset Management's ONCE Position: Q2 2015 in Review

EverPoint Asset Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q2 2015, closing a stake of 60,000 shares — an estimated $4.65M sold.

EverPoint Asset Management first reported a position in ONCE in Q1 2015 and held it in 1 quarter. The position peaked at $4.65M in Q1 2015. 109 funds tracked by Wall St. Rank hold ONCE as of Q2 2015.

  • EverPoint Asset Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q2 2015 after selling out during the quarter.
  • EverPoint Asset Management sold 60,000 Spark Therapeutics, Inc. Common Stock shares in Q2 2015, an estimated $4.65M.
  • EverPoint Asset Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 1 quarter.
  • EverPoint Asset Management's Spark Therapeutics, Inc. Common Stock position peaked at $4.65M in Q1 2015.
  • 109 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q2 2015.

Based on EverPoint Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.